Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Xuequan Zhu

Biographic Data

ID7765122
NAMEXuequan Zhu
GIVEN NAMESXuequan
FAMILY NAMEZhu
SIGNATUREZHU X
AFFILIATIONSBeijing Anding Hospital
ORCID0000-0001-5551-2810
VERIFIEDYes
TOTAL WORKS9
TOTAL CITATIONS0
WORKS AS AUTHOR9
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Prevalence, subtypes, and comorbidity of DSM-5 insomnia disorder among adults in Beijing, China

    Open Access•Lili Shang, Yanjie Zhao et al.•ARTICLE•BMC Public Health•2026

    The marked disparity between prevalent insomnia symptoms and formal diagnoses, compounded by significant psychiatric comorbidity, mandates a public health shift toward population-level screening and early intervention. This imperative includes adopting standardized diagnostics and implementing integrated, transdiagnostic treatment models as a pivotal preventive strategy

  • Remission trajectories and cognitive function in hospitalized youth with depressive episodes

    Open Access•Jie Yang, Nanxi Li et al.•ARTICLE•Frontiers in Psychiatry•2025

    The findings suggest that tailored interventions addressing baseline severity, anxiety, and cognitive support may be beneficial in hospitalized youth, with possible diagnostic relevance for bipolar depression

  • Increased antipsychotic drug concentration in hospitalized patients with mental disorders following Covid-19 infection

    Open Access•Rui Yang, Jin-Ling Wan et al.•ARTICLE•Frontiers in Psychiatry•2024

    Antipsychotic concentrations in hospitalized patients with mental disorders increased after COVID-19 infection, that may be related not only to COVID-19, but also to the use of Chinese patent medicines during infection. The pre-infection concentration and types of antipsychotics, patient's gender, and combination of traditional Chinese medicine or antibiotics, were factors found to correlate with increased drug concentrations and necessitate dose…

  • Factors associated with hospitalization times and length of stay in patients with bipolar disorder

    Open Access•Xiaoning Shi, Yingying Zhao et al.•ARTICLE•Frontiers in Psychiatry•2023

    www.ClinicalTrials.gov, Identifier: NCT01770704

  • Gender specific sexual dysfunction in patients with depression

    Open Access•Xinyu Liu, Zizhao Feng et al.•ARTICLE•Frontiers in Psychiatry•2023

    Our findings reveal the sex differences in the prevalence and severity of SD in patients with MDD. Evaluated with the ASEX score, female patients showed significantly worse sexual function than male patients. Being female, having a low monthly income, being aged 45 years or above, feeling sluggish, and having somatic symptoms may increase the risk of SD in patients with MDD

  • Correlation Between Word Frequency and 17 Items of Hamilton Scale in Major Depressive Disorder

    Open Access•Jiali Han, Yuan Feng et al.•ARTICLE•Frontiers in Psychiatry•2022

    In the clinical interview with MDD patients, the number of word frequencies based on HowNet sentiment dictionary may be beneficial in evaluating the severity of depressive symptoms

  • Efficacy of an Internet-Based Intervention for Subclinical Depression (MoodBox) in China

    Open Access•Xu Chen, Chen Xu et al.•ARTICLE•Frontiers in Psychiatry•2021

    Background: Subclinical depression is a prevalent mental health problem and increases the incidence of the onset of major mood disorders, such as major depressive disorder (MDD). Psychological interventions have been proved to be effective for reducing depressive symptoms for people with subclinical depression and can prevent the onset of MDD. However, people have limited access to face-to-face psychotherapy. Internet-based psychological interven…

  • Development and Internal Validation of a Novel Model to Identify Inflammatory Biomarkers of a Response to Escitalopram in Patients With Major Depressive Disorder

    Open Access•Jingjing Zhou, Jia Zhou et al.•ARTICLE•Frontiers in Psychiatry•2021

    Objective: The aim of our study was to identify immune- and inflammation-related factors with clinical utility to predict the clinical efficacy of treatment for depression. Study Design: This was a follow-up study. Participants who met the entry criteria were administered with escitalopram (5-10 mg/day) as an initial treatment. Self-evaluation and observer valuations were arranged at the end of weeks 0, 4, 8, and 12, with blood samples collected …

  • Mapping out a spectrum of the Chinese public’s discrimination toward the LGBT community

    Open Access•Yuanyuan Wang, Yuan Yuan Wang et al.•ARTICLE•BMC Public Health•2020

    Chinese LGBT groups consistently experience discrimination in various aspects of their daily lives. The prevalence of this discrimination is associated with the economic development of the province in which it occurs. In order to reduce discrimination, it is important for future studies to discover the underlying reasons for discrimination against LGBT individuals in China

No prominent works on this page.

  • Mapping out a spectrum of the Chinese public’s discrimination toward the LGBT community

    Open Access•Yuanyuan Wang, Yuan Yuan Wang et al.•ARTICLE•BMC Public Health•2020

    Chinese LGBT groups consistently experience discrimination in various aspects of their daily lives. The prevalence of this discrimination is associated with the economic development of the province in which it occurs. In order to reduce discrimination, it is important for future studies to discover the underlying reasons for discrimination against LGBT individuals in China

  • Efficacy of an Internet-Based Intervention for Subclinical Depression (MoodBox) in China

    Open Access•Xu Chen, Chen Xu et al.•ARTICLE•Frontiers in Psychiatry•2021

    Background: Subclinical depression is a prevalent mental health problem and increases the incidence of the onset of major mood disorders, such as major depressive disorder (MDD). Psychological interventions have been proved to be effective for reducing depressive symptoms for people with subclinical depression and can prevent the onset of MDD. However, people have limited access to face-to-face psychotherapy. Internet-based psychological interven…

  • Development and Internal Validation of a Novel Model to Identify Inflammatory Biomarkers of a Response to Escitalopram in Patients With Major Depressive Disorder

    Open Access•Jingjing Zhou, Jia Zhou et al.•ARTICLE•Frontiers in Psychiatry•2021

    Objective: The aim of our study was to identify immune- and inflammation-related factors with clinical utility to predict the clinical efficacy of treatment for depression. Study Design: This was a follow-up study. Participants who met the entry criteria were administered with escitalopram (5-10 mg/day) as an initial treatment. Self-evaluation and observer valuations were arranged at the end of weeks 0, 4, 8, and 12, with blood samples collected …

  • Correlation Between Word Frequency and 17 Items of Hamilton Scale in Major Depressive Disorder

    Open Access•Jiali Han, Yuan Feng et al.•ARTICLE•Frontiers in Psychiatry•2022

    In the clinical interview with MDD patients, the number of word frequencies based on HowNet sentiment dictionary may be beneficial in evaluating the severity of depressive symptoms

  • Factors associated with hospitalization times and length of stay in patients with bipolar disorder

    Open Access•Xiaoning Shi, Yingying Zhao et al.•ARTICLE•Frontiers in Psychiatry•2023

    www.ClinicalTrials.gov, Identifier: NCT01770704

  • Gender specific sexual dysfunction in patients with depression

    Open Access•Xinyu Liu, Zizhao Feng et al.•ARTICLE•Frontiers in Psychiatry•2023

    Our findings reveal the sex differences in the prevalence and severity of SD in patients with MDD. Evaluated with the ASEX score, female patients showed significantly worse sexual function than male patients. Being female, having a low monthly income, being aged 45 years or above, feeling sluggish, and having somatic symptoms may increase the risk of SD in patients with MDD

  • Increased antipsychotic drug concentration in hospitalized patients with mental disorders following Covid-19 infection

    Open Access•Rui Yang, Jin-Ling Wan et al.•ARTICLE•Frontiers in Psychiatry•2024

    Antipsychotic concentrations in hospitalized patients with mental disorders increased after COVID-19 infection, that may be related not only to COVID-19, but also to the use of Chinese patent medicines during infection. The pre-infection concentration and types of antipsychotics, patient's gender, and combination of traditional Chinese medicine or antibiotics, were factors found to correlate with increased drug concentrations and necessitate dose…

  • Remission trajectories and cognitive function in hospitalized youth with depressive episodes

    Open Access•Jie Yang, Nanxi Li et al.•ARTICLE•Frontiers in Psychiatry•2025

    The findings suggest that tailored interventions addressing baseline severity, anxiety, and cognitive support may be beneficial in hospitalized youth, with possible diagnostic relevance for bipolar depression

  • Prevalence, subtypes, and comorbidity of DSM-5 insomnia disorder among adults in Beijing, China

    Open Access•Lili Shang, Yanjie Zhao et al.•ARTICLE•BMC Public Health•2026

    The marked disparity between prevalent insomnia symptoms and formal diagnoses, compounded by significant psychiatric comorbidity, mandates a public health shift toward population-level screening and early intervention. This imperative includes adopting standardized diagnostics and implementing integrated, transdiagnostic treatment models as a pivotal preventive strategy

Medicine (7 works) · Depression (economics (5 works) · Internal Medicine (5 works) · Psychiatry (5 works) · Major depressive disorder (4 works) · Psychology (4 works) · Anxiety (3 works) · Clinical Psychology (3 works) · Clinical Psychology (3 works) · Depressive symptoms (3 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae